A supplier suspends shipping to Singapore after 19 consecutive customs detentions
The route did not close because of a rule about peptides.
November 2024 — Vol. 1, No. 11
Page 2 of 4 of this archive, newest first.
Also filed — page 2
the rolling newsroom, November 2024Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 35% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
From the floor in Nantong: 13 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a SGN mazdutide lot at 99.2%, against 96.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
SURMOUNT-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A shortage listing ends. 21 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Medutest result on a Xi'an tirzepatide lot lands 2.1 points above the supplier’s stated figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What changed at FGP in November, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Norway guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What the new Mexico guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 22% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 15 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
TRIUMPH-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Australia health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
From the floor in Wuxi: 3 posters, one theme
Reported from the sessions, and from the two hours afterwards.
ERP names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The 7-day notice: how a compounding wind-down works in Turkey
The document is four pages. Three of them are about dates.
Halvard & Pike Apothecary of Portland, Maine closes after 10 years
A proper account of an operation that existed, and of what closing it cost.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Canada pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
South Korea declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
What the new Saudi Arabia guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Hangzhou: 6 posters, one theme
Reported from the sessions, and from the two hours afterwards.
VendorInvestigate result on a Guangzhou retatrutide lot lands 3.9 points above the supplier’s stated figure
The result is unremarkable. What the report states alongside it is not.
What changed at FGP in November, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.